Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: SORENESS; JITTERINESS; UNABLE TO SLEEP; FATIGUE; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 71 year old of unspecified sex. The patient''s height, and weight were not reported. The patient''s concurrent conditions included seasonal allergy, and codeine allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced soreness. On 12-APR-2021, the subject experienced jitteriness. On 12-APR-2021, the subject experienced unable to sleep. On 12-APR-2021, the subject experienced fatigue. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from jitteriness, unable to sleep, and fever on 13-APR-2021, fatigue on 14-APR-2021, and headache on 15-APR-2021, and was recovering from soreness. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166